Related Experiment Video
Updated: Jun 10, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Biomarkers in Barrett's Esophagus
1Departments of Medicine, VA North Texas Health Care System and the University of Texas Southwestern Medical School, and the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas.
Molecular biomarkers show promise for patients with Barrett's esophagus, aiding in risk stratification, dysplasia diagnosis, and predicting treatment response. Clinical use is anticipated as validation studies progress.
Area of Science:
- Gastroenterology
- Molecular Diagnostics
- Oncology
Background:
- Barrett's esophagus is a precursor to esophageal adenocarcinoma.
- Molecular biomarkers can indicate disease states.
- Current clinical use of biomarkers for Barrett's esophagus is not standard.
Purpose of the Study:
- To review the progress of molecular biomarkers in Barrett's esophagus.
- To focus on biomarkers closest to clinical application.
- To discuss biomarker use in risk stratification, dysplasia diagnosis, and predicting therapy response.
Main Methods:
- Review of current literature on molecular biomarkers for Barrett's esophagus.
- Focus on biomarkers advanced in validation studies.
- Categorization of biomarker applications into risk stratification, diagnosis, and treatment prediction.
Main Results:
- Several molecular biomarkers are being investigated for Barrett's esophagus.
- Biomarkers show potential in stratifying neoplastic progression risk.
- Biomarkers may assist in diagnosing dysplasia and predicting response to ablative therapies.
Conclusions:
- Molecular biomarkers hold significant potential for managing Barrett's esophagus.
- Further validation studies are necessary for routine clinical integration.
- Biomarkers are expected to become integral to clinical practice in the near future.
Related Concept Videos
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Gastroesophageal Reflux Disease
Upper GI Series: Barium Swallow
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...

